1. Home
  2. BDTX vs WHG Comparison

BDTX vs WHG Comparison

Compare BDTX & WHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • WHG
  • Stock Information
  • Founded
  • BDTX 2014
  • WHG 1983
  • Country
  • BDTX United States
  • WHG United States
  • Employees
  • BDTX N/A
  • WHG N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • WHG Investment Managers
  • Sector
  • BDTX Health Care
  • WHG Finance
  • Exchange
  • BDTX Nasdaq
  • WHG Nasdaq
  • Market Cap
  • BDTX 144.9M
  • WHG 148.5M
  • IPO Year
  • BDTX 2020
  • WHG 2002
  • Fundamental
  • Price
  • BDTX $2.48
  • WHG $15.36
  • Analyst Decision
  • BDTX Strong Buy
  • WHG
  • Analyst Count
  • BDTX 4
  • WHG 0
  • Target Price
  • BDTX $15.50
  • WHG N/A
  • AVG Volume (30 Days)
  • BDTX 476.4K
  • WHG 17.1K
  • Earning Date
  • BDTX 11-05-2024
  • WHG 02-12-2025
  • Dividend Yield
  • BDTX N/A
  • WHG 3.97%
  • EPS Growth
  • BDTX N/A
  • WHG N/A
  • EPS
  • BDTX N/A
  • WHG 0.32
  • Revenue
  • BDTX N/A
  • WHG $92,368,000.00
  • Revenue This Year
  • BDTX N/A
  • WHG N/A
  • Revenue Next Year
  • BDTX N/A
  • WHG N/A
  • P/E Ratio
  • BDTX N/A
  • WHG $47.75
  • Revenue Growth
  • BDTX N/A
  • WHG 6.16
  • 52 Week Low
  • BDTX $2.31
  • WHG $11.00
  • 52 Week High
  • BDTX $7.66
  • WHG $18.03
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 43.96
  • WHG 45.07
  • Support Level
  • BDTX $2.43
  • WHG $15.23
  • Resistance Level
  • BDTX $2.66
  • WHG $15.79
  • Average True Range (ATR)
  • BDTX 0.16
  • WHG 0.50
  • MACD
  • BDTX 0.05
  • WHG -0.08
  • Stochastic Oscillator
  • BDTX 48.81
  • WHG 23.78

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About WHG Westwood Holdings Group Inc

Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals, and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high-net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: